Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bela Merkely

Showing results (271-280 of 296) with videos related to

Pageof 30
Sort By:
Journal of the American College of Cardiology|April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIThomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 30, 2012
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management, , , et al.
International Journal of Cardiology. Heart & Vasculature|October 13, 2025
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trialElfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
JAMA|March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical TrialStefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
BMJ (Clinical Research Ed.)|June 14, 2012
Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohortsTessa S S Genders, Ewout W Steyerberg, M G Myriam Hunink, et al.
Circulation|November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failureMilton Packer, John J V McMurray, Akshay S Desai, et al.
Pageof 30

Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Journal of the American College of Cardiology|April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIThomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2025
Comparative 30-day Echocardiographic Outcomes of Myval versus Sapien and Evolut THVs: Insights from LANDMARK TrialOsama Soliman, Elfatih A Hasabo, Niels van Royen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 30, 2012
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management, , , et al.
International Journal of Cardiology. Heart & Vasculature|October 13, 2025
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trialElfatih A Hasabo, Niels van Royen, Ignacio J Amat-Santos, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
JAMA|March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical TrialStefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
BMJ (Clinical Research Ed.)|June 14, 2012
Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohortsTessa S S Genders, Ewout W Steyerberg, M G Myriam Hunink, et al.
Circulation|November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failureMilton Packer, John J V McMurray, Akshay S Desai, et al.
Pageof 30